BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zivkovic PM, Matetic A, Tadin Hadjina I, Rusic D, Vilovic M, Supe-Domic D, Borovac JA, Mudnic I, Tonkic A, Bozic J. Serum Catestatin Levels and Arterial Stiffness Parameters Are Increased in Patients with Inflammatory Bowel Disease. J Clin Med. 2020;9. [PMID: 32110996 DOI: 10.3390/jcm9030628] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Chen GX. Urotensin II level is elevated in inflammatory bowel disease patients. World J Gastroenterol 2022; 28(35): 5230-5232 [DOI: 10.3748/wjg.v28.i35.5230] [Reference Citation Analysis]
2 Kumric M, Vrdoljak J, Dujic G, Supe-domic D, Ticinovic Kurir T, Dujic Z, Bozic J. Serum Catestatin Levels Correlate with Ambulatory Blood Pressure and Indices of Arterial Stiffness in Patients with Primary Hypertension. Biomolecules 2022;12:1204. [DOI: 10.3390/biom12091204] [Reference Citation Analysis]
3 Kljakovic-gaspic T, Tokic D, Martinovic D, Kumric M, Supe-domic D, Stojanovic Stipic S, Delic N, Vrdoljak J, Vilovic M, Ticinovic Kurir T, Bozic J. Prognostic Value of Catestatin in Severe COVID-19: An ICU-Based Study. JCM 2022;11:4496. [DOI: 10.3390/jcm11154496] [Reference Citation Analysis]
4 Wu H, Xu M, Hao H, Hill MA, Xu C, Liu Z. Endothelial Dysfunction and Arterial Stiffness in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. J Clin Med 2022;11:3179. [PMID: 35683564 DOI: 10.3390/jcm11113179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Simac P, Perkovic D, Bozic I, Matijas M, Gugo K, Martinovic D, Bozic J. Serum catestatin levels in patients with rheumatoid arthritis. Sci Rep 2022;12:3812. [PMID: 35264632 DOI: 10.1038/s41598-022-07735-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Vrdoljak J, Kumric M, Vilovic M, Martinovic D, Tomic IJ, Krnic M, Ticinovic Kurir T, Bozic J. Effects of Olive Oil and Its Components on Intestinal Inflammation and Inflammatory Bowel Disease. Nutrients 2022;14:757. [DOI: 10.3390/nu14040757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kumric M, Zivkovic PM, Ticinovic Kurir T, Vrdoljak J, Vilovic M, Martinovic D, Bratanic A, Lizatovic IK, Bozic J. Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease. Diagnostics 2022;12:45. [DOI: 10.3390/diagnostics12010045] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Muntjewerff EM, Parv K, Mahata SK, van Riessen NK, Phillipson M, Christoffersson G, van den Bogaart G. The anti-inflammatory peptide Catestatin blocks chemotaxis. J Leukoc Biol 2021. [PMID: 34939227 DOI: 10.1002/JLB.3CRA1220-790RR] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Muntjewerff EM, Christoffersson G, Mahata SK, van den Bogaart G. Putative regulation of macrophage-mediated inflammation by catestatin. Trends Immunol 2022;43:41-50. [PMID: 34844850 DOI: 10.1016/j.it.2021.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Bozic J, Kumric M, Ticinovic Kurir T, Urlic H, Martinovic D, Vilovic M, Tomasovic Mrcela N, Borovac JA. Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective. Biomedicines 2021;9:1757. [PMID: 34944578 DOI: 10.3390/biomedicines9121757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Alicic D, Martinovic D, Rusic D, Zivkovic PM, Tadin Hadjina I, Vilovic M, Kumric M, Tokic D, Supe-Domic D, Lupi-Ferandin S, Bozic J. Urotensin II levels in patients with inflammatory bowel disease. World J Gastroenterol 2021; 27(36): 6142-6153 [PMID: 34629825 DOI: 10.3748/wjg.v27.i36.6142] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Vrdoljak J, Kumric M, Ticinovic Kurir T, Males I, Martinovic D, Vilovic M, Bozic J. Effects of Wine Components in Inflammatory Bowel Diseases. Molecules 2021;26:5891. [PMID: 34641434 DOI: 10.3390/molecules26195891] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Muntjewerff EM, Tang K, Lutter L, Christoffersson G, Nicolasen MJT, Gao H, Katkar GD, Das S, Ter Beest M, Ying W, Ghosh P, El Aidy S, Oldenburg B, van den Bogaart G, Mahata SK. Chromogranin A regulates gut permeability via the antagonistic actions of its proteolytic peptides. Acta Physiol (Oxf) 2021;232:e13655. [PMID: 33783968 DOI: 10.1111/apha.13655] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
14 Chavez L, Mayrovitz HN. Assessing the Impact of Helicobacter pylori Infection and Inflammatory Bowel Disease on Pulse Wave Velocity and Arterial Stiffness. Cureus 2021;13:e14944. [PMID: 34123641 DOI: 10.7759/cureus.14944] [Reference Citation Analysis]
15 Luketin M, Mizdrak M, Boric-Skaro D, Martinovic D, Tokic D, Vilovic M, Supe-Domic D, Ticinovic Kurir T, Bozic J. Plasma Catestatin Levels and Advanced Glycation End Products in Patients on Hemodialysis. Biomolecules 2021;11:456. [PMID: 33803864 DOI: 10.3390/biom11030456] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
16 Wang X, Chen S, Xiang H, Liang Z, Lu H. Role of sphingosine-1-phosphate receptors in vascular injury of inflammatory bowel disease. J Cell Mol Med 2021;25:2740-9. [PMID: 33595873 DOI: 10.1111/jcmm.16333] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Vrdoljak J, Vilović M, Živković PM, Tadin Hadjina I, Rušić D, Bukić J, Borovac JA, Božić J. Mediterranean Diet Adherence and Dietary Attitudes in Patients with Inflammatory Bowel Disease. Nutrients 2020;12:E3429. [PMID: 33171662 DOI: 10.3390/nu12113429] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
18 Brnic D, Martinovic D, Zivkovic PM, Tokic D, Vilovic M, Rusic D, Tadin Hadjina I, Libers C, Glumac S, Supe-Domic D, Tonkic A, Bozic J. Inactive matrix Gla protein is elevated in patients with inflammatory bowel disease. World J Gastroenterol 2020; 26(32): 4866-4877 [PMID: 32921963 DOI: 10.3748/wjg.v26.i32.4866] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]